Hanover Insurance Group I... (THG)
NYSE: THG
· Real-Time Price · USD
166.77
-0.08 (-0.05%)
At close: May 22, 2025, 3:59 PM
166.99
0.13%
After-hours: May 22, 2025, 05:49 PM EDT
Hanover Insurance Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|
| Core Commercial Lines Segment Revenue | 2.32B | 2.22B | 1.95B | 1.93B | 1.84B | 1.82B | 1.71B | 1.58B |
| Core Commercial Lines Segment Revenue Growth | +4.84% | +13.65% | +1.09% | +4.63% | +1.31% | +6.70% | +7.92% | n/a |
| Other Operating Segment Revenue | 12.4M | 2.44B | 2.11B | n/a | n/a | n/a | n/a | n/a |
| Other Operating Segment Revenue Growth | -99.49% | +15.59% | n/a | n/a | n/a | n/a | n/a | n/a |
| Personal Lines Segment Revenue | 2.56B | 1.35B | 1.19B | n/a | n/a | n/a | n/a | n/a |
| Personal Lines Segment Revenue Growth | +89.70% | +13.68% | n/a | n/a | n/a | n/a | n/a | n/a |
| Specialty Lines Segment Revenue | 1.41B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Specialty Lines Segment Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | n/a | n/a | -263.4M | n/a | n/a | n/a | -151.9M | n/a | -17.5M | n/a | n/a | n/a | -101.9M | n/a | n/a | -104.3M | 1.05B | n/a | 992.4M | 986.5M | 959.3M | n/a | 966.6M | 982.3M | 964.5M | n/a | 930.7M | 1.1B | 1.1B | -102.2M | 1.16B | 1.03B | 1.22B | n/a | 1.1B | 1.18B | 1.12B | n/a | 1.12B | 1.14B | 1.22B |
| Selling, General, and Administrative Revenue Growth | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | -100.00% | -109.92% | n/a | -100.00% | +0.60% | +2.84% | n/a | -100.00% | -1.60% | +1.85% | n/a | -100.00% | -15.76% | +0.53% | -1175.34% | -108.80% | +12.32% | -15.46% | n/a | -100.00% | -6.22% | +5.23% | n/a | -100.00% | -1.87% | -6.32% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |